Literature DB >> 32044557

Does REM sleep behavior disorder change in the progression of Parkinson's disease?

M Figorilli1, A R Marques2, T Vidal3, L Delaby3, M Meloni4, B Pereira5, C Lambert5, M Puligheddu4, F Durif2, M L Fantini6.   

Abstract

OBJECTIVES/
BACKGROUND: Rapid eye movement (REM) Sleep Behavior Disorder (RBD) in Parkinson's disease (PD) may be associated with a malignant phenotype. Despite its prognostic value, little is known about the time course of RBD in PD. In this study, we aimed to ascertain whether or not RBD is a stable feature in PD. In this study, we prospectively evaluated clinical and neurophysiological features of RBD, including REM Sleep Without Atonia (RSWA), in PD patients with RBD at baseline and after three years then assessed whether the changes in measures of RSWA parallel the progression of PD. PATIENTS/
METHODS: In sum, 22 (17M, mean age 64.0 ± 6.9 years) moderate-to-advanced PD patients (mean PD duration at baseline:7.6±4.8 years) with RBD, underwent a video-polysomnography (vPSG) recording and clinical and neuropsychological assessment at baseline and after three years.
RESULTS: At follow-up, the self-assessed frequency of RBD symptoms increased in six patients, decreased in six and remained stable in 10, while RSWA measures significantly increased in all subjects. At follow-up, patients showed worse H&Y stage (p = 0.02), higher dopaminergic doses (p = 0.05) and they performed significantly worse in phonetic and semantic fluency tests (p = 0.02; p = 0.04). Changes in RSWA correlated significantly with the severity in levodopa-induced dyskinesia (r = 0.61,p = 0.05) and motor fluctuation (r = 0.54,p = 0.03) scores, and with the worsening of executive functions (r = 0.78,p = 0.001) and visuo-spatial perception (r = -0.57,p = 0.04).
CONCLUSION: Despite the subjective improvement of RBD symptoms in one-fourth of PD patients, all RSWA measures increased significantly at follow-up, and their changes correlated with the clinical evolution of motor and non-motor symptoms. RBD is a long-lasting feature in PD and RSWA is a marker of the disease's progression.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Longitudinal; Parkinson's disease; Progression; REM sleep behavior disorder; REM sleep without atonia

Mesh:

Substances:

Year:  2020        PMID: 32044557     DOI: 10.1016/j.sleep.2019.12.013

Source DB:  PubMed          Journal:  Sleep Med        ISSN: 1389-9457            Impact factor:   3.492


  13 in total

1.  Correlation of Antidepressant Use and Symptom Time Period in Dream Enactment Behaviors.

Authors:  Yukiyoshi Sumi; Hiroshi Kadotani; Yuji Ozeki
Journal:  Mov Disord Clin Pract       Date:  2021-12-03

2.  Preoperative REM Sleep Behavior Disorder and Subthalamic Nucleus Deep Brain Stimulation Outcome in Parkinson Disease 1 Year After Surgery.

Authors:  Elsa Besse-Pinot; Bruno Pereira; Franck Durif; Maria Livia Fantini; Elodie Durand; Bérengère Debilly; Philippe Derost; Caroline Moreau; Elodie Hainque; Tiphaine Rouaud; Alexandre Eusebio; Isabelle Benatru; Sophie Drapier; Dominique Guehl; Olivier Rascol; David Maltête; Ouhaïd Lagha-Boukbiza; Caroline Giordana; Melissa Tir; Stéphane Thobois; Lucie Hopes; Cécile Hubsch; Béchir Jarraya; Anne-Sophie Rolland; Jean-Christophe Corvol; David Devos; Ana Marques
Journal:  Neurology       Date:  2021-10-19       Impact factor: 9.910

3.  Sleep and affective disorders in relation to Parkinson's disease risk among older women from the Women's Health Initiative.

Authors:  Hind A Beydoun; Jiu-Chiuan Chen; Nazmus Saquib; Michelle J Naughton; May A Beydoun; Aladdin H Shadyab; Lauren Hale; Alan B Zonderman
Journal:  J Affect Disord       Date:  2022-06-22       Impact factor: 6.533

Review 4.  Longitudinal Studies of Sleep Disturbances in Parkinson's Disease.

Authors:  Zheyu Xu; Kirstie N Anderson; Nicola Pavese
Journal:  Curr Neurol Neurosci Rep       Date:  2022-08-26       Impact factor: 6.030

Review 5.  Polysomnographic Predictors of Sleep, Motor, and Cognitive Dysfunction Progression in Parkinson's Disease.

Authors:  Femke Dijkstra; Ilse de Volder; Mineke Viaene; Patrick Cras; David Crosiers
Journal:  Curr Neurol Neurosci Rep       Date:  2022-08-22       Impact factor: 6.030

6.  REM sleep behavior disorder and cerebrospinal fluid alpha-synuclein, amyloid beta, total tau and phosphorylated tau in Parkinson's disease: a cross-sectional and longitudinal study.

Authors:  Fardin Nabizadeh; Kasra Pirahesh; Parya Valizadeh
Journal:  J Neurol       Date:  2022-04-15       Impact factor: 6.682

7.  Association Between Dopaminergic Medications and the Evolution of REM Sleep Behavior Disorder in Parkinson's Disease.

Authors:  Ruihua Cao; Ruolin Ma; Kai Wang; Panpan Hu
Journal:  Front Neurol       Date:  2022-06-10       Impact factor: 4.086

8.  Pre-gelled Electrode Grid for Self-Applied EEG Sleep Monitoring at Home.

Authors:  Carlos F da Silva Souto; Wiebke Pätzold; Marina Paul; Stefan Debener; Karen Insa Wolf
Journal:  Front Neurosci       Date:  2022-06-24       Impact factor: 5.152

9.  Association of sleep disturbance and freezing of gait in Parkinson disease: prevention/delay implications.

Authors:  Xiaohui Tang; Lijia Yu; Jingyun Yang; Wenjing Guo; Ying Liu; Yaling Xu; Xijin Wang
Journal:  J Clin Sleep Med       Date:  2021-04-01       Impact factor: 4.062

10.  REM Sleep Behavior Disorder in Parkinson's Disease: Change in Cognitive, Psychiatric, and Functional Outcomes from Baseline to 16-47-Month Follow-Up.

Authors:  Ryan Van Patten; Zanjbeel Mahmood; Delaney Pickell; Jacqueline E Maye; Scott Roesch; Elizabeth W Twamley; J Vincent Filoteo; Dawn M Schiehser
Journal:  Arch Clin Neuropsychol       Date:  2022-01-17       Impact factor: 3.448

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.